Search

Displaying results 6211 - 6220 of 10000 in total
  1. Drug

    Omiganan

    go.drugbank.com/drugs/DB06610
    Investigational

    Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections.

  2. Drug

    Amineptine

    go.drugbank.com/drugs/DB04836
    ApprovedIllicitWithdrawn

    The Food and Drug Administration suspended the marketing authorisation for Survector in 1999 and France withdrew it from the market, however several developing countries continued to produce it up until

  3. Drug

    Acoltremon

    go.drugbank.com/drugs/DB19202
    ApprovedInvestigational

    Acoltremon is under investigation in clinical trial NCT05493111 (A Long-term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512).

    Synonyms: N-(4-methoxyphenyl)-p-menthanecarboxamide, Cyclohexanecarboxamide, n-(4-methoxyphenyl)-5-methyl-2-(1-methylethyl)-, (1r,2s,5r)-
  4. Drug

    Tofisopam

    go.drugbank.com/drugs/DB08811
    Investigational

    The D-enantiomer ([dextofisopam]) is currently in phase II trials in the U.S. for the treatment of irritable bowel syndrome. … Although Tofisopam is not approved for sale in North America, it is approved for use in various countries worldwide, including parts of Europe.

  5. Drug

    Aminoimidazole carboxamide

    go.drugbank.com/drugs/DB06143
    Investigational

  6. Drug

    Semaxanib

    go.drugbank.com/drugs/DB06436
    Investigational

  7. Drug

    Fipamezole

    go.drugbank.com/drugs/DB06585
    Investigational

  8. Drug

    TRU-015

    go.drugbank.com/drugs/DB05580
    Investigational

  9. Drug

    CRD5

    go.drugbank.com/drugs/DB05587
    Experimental

  10. Drug

    Freselestat

    go.drugbank.com/drugs/DB03925
    Experimental